3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Laryngeal Neoplasms
3
Head and Neck Neoplasms
3
Uterine Cervical Neoplasms
2
Stomatitis
2
Squamous Cell Carcinoma of Head and Neck
2
Skin Neoplasms
2
Hematologic Neoplasms
2
Dyspareunia
2
Carcinoma, Hepatocellular
2
Carcinoma, Basal Cell
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Vomiting
1
Vaginal Neoplasms
1
Urinary Bladder Neoplasms
1
Squamous Intraepithelial Lesions
1
Soft Tissue Neoplasms
1
Radiodermatitis
1
Prostatic Neoplasms
1
Papillomavirus Infections
1
Pain
1
Ovarian Neoplasms
1
Neoplasms
1
Mucositis
1
HIV Infections
1
Endometrial Neoplasms
1
Eczema
1
Dermatitis
1
Cicatrix
1
Cancer Pain
1
Interventions
human papillomavirus vaccine, L1 type 16, 18
35
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
23
Papillomavirus Vaccines
14
Data Collection
7
Blood Specimen Collection
7
Vaccines
6
Vaccines, Synthetic
5
Educational Status
5
Radiotherapy, Intensity-Modulated
4
Human Papillomavirus Recombinant Vaccine nonavalent
4
Early Intervention, Educational
4
Vaginal Smears
3
Surveys and Questionnaires
3
Polymerase Chain Reaction
3
Paclitaxel
3
Methods
3
Engerix-B
3
Colposcopy
3
Cisplatin
3
halofantrine
2
fludarabine phosphate
2
fludarabine
2
aldesleukin
2
Watchful Waiting
2
Taxes
2
Patient Navigation
2
Papanicolaou Test
2
Observation
2
Light Coagulation
2
Imiquimod
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Papillomavirus Infections
×
Laser Therapy
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts